Market leadership Volcano Corporation is a global leader in intravascular imaging and physiology across coronary and peripheral applications, suggesting strong credibility and potential for upsell of advanced imaging platforms and compatible consumables to existing and new cardiovascular customers.

Expansion opportunities History of acquisitions and strategic growth indicates potential for cross-sell with acquired technologies and integration opportunities for complementary devices, physiologic tools, and peripheral therapy solutions.

Strategic partnerships With a high-value profile and prior Philips acquisition, target large health systems and distributors for bundled solutions, leveraging Volcano’s multi-modality platform to replace competing imaging workflows and capture system-wide contracts.

Financial potential Revenue in the range of $100M–$250M signals mid-market scale with room for portfolio expansion, enabling sales efforts around higher-margin platforms, service agreements, and extended maintenance plans.

Customer-centric value Emphasize how Volcano’s imaging and therapy platforms improve diagnostic clarity and procedural outcomes while reducing invasiveness, aligning with hospital efficiency goals and payer-focused cost-benefit narratives.